Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Public ClinicalTrials.gov record NCT02485704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
Study identification
- NCT ID
- NCT02485704
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ParaPRO LLC
- Industry
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Interventions
- spinosad topical suspension, 0.9% Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 9, 2017
- Primary completion
- Aug 2, 2018
- Completion
- Aug 2, 2018
- Last update posted
- May 20, 2021
2017 – 2018
United States locations
- U.S. sites
- 7
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Saint Joseph's Clinical Research | Anaheim | California | 92804 | — |
| Long Beach Clinical Trial Services | Long Beach | California | 90806 | — |
| The Chappel Group Research | Kissimmee | Florida | 34744 | — |
| DermDox Centers for Dermatology | Hazleton | Pennsylvania | 18201 | — |
| Paddington Testing Company | Philadelphia | Pennsylvania | 19103 | — |
| West Houston Clinical Research Service | Houston | Texas | 77055 | — |
| Discovery Clinical Trials | McAllen | Texas | 78503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02485704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02485704 live on ClinicalTrials.gov.